|
TMEM126A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.917150E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.536000E-03 |
| Normal-vs-Stage2 |
3.236800E-03 |
| Normal-vs-Stage3 |
9.058000E-01 |
| Normal-vs-Stage4 |
1.050290E-02 |
| Stage1-vs-Stage2 |
4.123600E-02 |
| Stage1-vs-Stage3 |
1.990480E-02 |
| Stage1-vs-Stage4 |
4.560200E-01 |
| Stage2-vs-Stage3 |
4.102000E-03 |
| Stage2-vs-Stage4 |
1.165840E-01 |
| Stage3-vs-Stage4 |
1.793700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.986200E-04 |
| Normal-vs-AfricanAmerican |
4.918200E-01 |
| Normal-vs-Asian |
1.125630E-02 |
| Caucasian-vs-AfricanAmerican |
7.383600E-02 |
| Caucasian-vs-Asian |
4.266000E-02 |
| AfricanAmerican-vs-Asian |
3.103500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.436400E-03 |
| Normal-vs-Female |
1.086370E-02 |
| Male-vs-Female |
7.888000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.819600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.939470E-03 |
| Normal-vs-Age(61-80Yrs) |
7.139700E-02 |
| Normal-vs-Age(81-100Yrs) |
5.124500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.049200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.434200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.190820E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.296200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.569200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.241760E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.630430E-01 |
| Normal-vs-Grade 2 |
7.736000E-03 |
| Normal-vs-Grade 3 |
1.150020E-02 |
| Normal-vs-Grade 4 |
3.439800E-01 |
| Grade 1-vs-Grade 2 |
8.329200E-01 |
| Grade 1-vs-Grade 3 |
8.072200E-01 |
| Grade 1-vs-Grade 4 |
6.209000E-01 |
| Grade 2-vs-Grade 3 |
9.524200E-01 |
| Grade 2-vs-Grade 4 |
3.752000E-01 |
| Grade 3-vs-Grade 4 |
3.883800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.40859999997467E-06 |
| Normal-vs-ccB subtype |
8.716400E-01 |
| ccA subtype-vs-ccB subtype |
4.40280000002513E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.248200E-02 |
| Normal-vs-N1 |
6.496000E-01 |
| N0-vs-N1 |
8.930200E-02 |
|
|
